The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 357.50
Bid: 350.00
Ask: 365.00
Change: 6.00 (1.69%)
Spread: 15.00 (4.286%)
Open: 357.50
High: 360.00
Low: 360.00
Prev. Close: 354.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Share Dealings

5 Dec 2023 13:54

RNS Number : 7580V
Focusrite PLC
05 December 2023
 

Focusrite plc

 

("the Company" or "the Group")

 

Focusrite plc FY23 Discretionary Directors Bonus (FY23 Bonus)

Director Share Dealings

 

Focusrite plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 28 November 2023 it awarded ordinary shares of 0.1p each in the capital of the Company ("Shares") to Tim Carroll, Group CEO of the Company and Sally McKone, Group CFO of the Company (each Persons Discharging Managerial Responsibilities ("PDMRs")), as listed below.

Director

No. of Shares awarded

Tim Carroll

8,933

Sally McKone

15,622

 

The Shares were awarded to the PDMRs as part of the Company's annual bonus arrangements for the 2023 financial year. Each PDMR elected to convert a portion of their annual bonus into Shares, and in return received an award of further Shares on a 1:1 basis.

 

Neither PDMR may ordinarily sell, transfer, assign or dispose of the Shares for a period of two years.

 

The award of the shares was settled in part by the transfer of 8,933 ordinary shares to Mr. Carroll and the transfer of 15,622 ordinary shares to Ms McKone and in part with a cash payment equal to market value of 7,922 ordinary shares to meet Mr. Carroll's liability to income tax and employee national insurance arising on award of the bonus shares and 13,853 ordinary shares to meet Ms McKone's liability to income tax and employee national insurance arising on award of the bonus shares.

 

Following the award Mr. Carroll's beneficial holding is 97,446 Ordinary Shares in the Company representing 0.16% of the total number of shares in the Company and Ms McKone's beneficial holding is 27,630 Ordinary Shares in the Company representing 0.04% of the total number of shares in the Company.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Tim Carroll

 

2

Reason for the notification

a)

Position/status

 

Group Chief Executive Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

Legal Entity Identifier

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Acquisition of shares pursuant to Focusrite plc's annual bonus arrangements for the 2023 financial year

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Nil

8,933

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

 

e)

Date of the transaction

28 November 2023

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

Sally McKone

 

2

Reason for the notification

a)

Position/status

 

Group Chief Financial Officer

?

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

Legal Entity Identifier

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Acquisition of shares pursuant to Focusrite plc's annual bonus arrangements for the 2021 financial year

c)

Price(s) and volume(s)

 

Prices per share

Volumes Acquired

Nil

15,622

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

 

e)

Date of the transaction

28 November 2023

f)

Place of the transaction

Outside a trading venue

 

-ends-

 

Enquiries:

 

Focusrite plc:

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

Investec Bank plc (Nominated Adviser and Joint Broker)

David Flin

Edward Knight

William Brinkley

 

Peel Hunt LLP (Joint broker)

Paul Gillam

Michael Burke

James Smith

+44 20 7597 5970

 

 

 

 

+44 20 7418 8900

Belvedere Communications

John West

Llew Angus

 +44 207 653 8703

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

Notes to Editors

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under eleven established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal Audio, Linea Research Sequential, Oberheim and Sonnox.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro offer audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesizers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Linea designs, develops, manufactures and sells market innovative professional audio equipment globally. Sequential designs and manufactures high end analogue synthesizers under the Sequential and Oberheim brands. Sonnox is a leading designer of innovative, high quality, award winning audio processing software plug-ins for professional audio engineers.

The Company has offices in four continents and a global customer base with a distribution network covering approximately 240 territories.

Focusrite plc is traded on the AIM market, London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXBDDDUGDGXU
Date   Source Headline
25th Apr 20247:00 amRNSInterim Results
22nd Apr 20246:09 pmRNSTR-1
9th Apr 20247:00 amRNSInvestor Presentation via Investor Meet Company
8th Apr 20247:00 amRNSNotice of Interim Results
22nd Mar 20243:36 pmRNSNotification of PDMR Transactions
22nd Mar 20248:01 amRNSTR-1
20th Mar 20247:01 amRNSTR-1
19th Mar 20244:44 pmRNSNotification of PDMR Transactions
18th Mar 20247:00 amRNSTrading Update
14th Feb 20243:10 pmRNSNotification of PDMR Transactions
7th Feb 20242:25 pmRNSTR-1
19th Jan 202412:59 pmRNSResult of AGM
19th Jan 20247:00 amRNSAGM Statement
8th Jan 20244:36 pmRNSTR-1
2nd Jan 20247:00 amRNSPHIL DUDDERIDGE AWARDED OBE
19th Dec 20237:00 amRNSAcquisition of Sheriff Technology Limited
7th Dec 20233:58 pmRNSTR-1
5th Dec 20232:02 pmRNSGrant of Share Options to PDMRs
5th Dec 20231:54 pmRNSDirector Share Dealings
29th Nov 20234:51 pmRNSTR-1
28th Nov 20237:00 amRNSFinal Results
17th Nov 202310:27 amRNSTR-1
17th Nov 20237:00 amRNSTR-1
7th Nov 20237:00 amRNSTR-1
31st Oct 20237:00 amRNSNotice of Final Results
14th Sep 20237:00 amRNSTrading Update for the year ended 31 August 2023
9th Jun 202310:54 amRNSNotification of PDMR Transactions
16th May 20237:20 amRNSChange of Registered Office
3rd May 20237:00 amRNSPDMR Dealings
26th Apr 20232:39 pmRNSInterim Dividend Timetable Correction
25th Apr 20237:00 amRNSHalf year results
11th Apr 20231:28 pmRNSNotice of Interim Results
14th Mar 20237:00 amRNSTrading Update
22nd Feb 20239:25 amRNSNotification of PDMR Transactions
7th Feb 20239:51 amRNSPDMR Dealings
3rd Feb 202312:49 pmRNSResult of AGM
3rd Feb 20237:00 amRNSAGM Statement and Update on Trading
18th Jan 20237:00 amRNSSettlement of Share Options
18th Jan 20237:00 amRNSNotification of PDMR Transaction
16th Jan 202311:43 amRNSSettlement of Share Options
22nd Dec 202211:49 amRNSGrant of Share Options to PDMRs
20th Dec 20227:00 amRNSAcquisition of Sonnox Limited
14th Dec 20227:00 amRNSPDMR
8th Dec 20229:05 amRNSSecond Price Monitoring Extn
8th Dec 20229:00 amRNSPrice Monitoring Extension
8th Dec 20227:00 amRNSFinal Results
7th Dec 202211:12 amRNSShare issuance to Employee Benefit Trust
21st Nov 20227:00 amRNSChange to Final Results announcement date
7th Nov 20227:00 amRNSNotice of Final Results
27th Oct 20221:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.